Moderna, Merck Breakthrough Could Usher In Cancer Vaccines

Moderna and Merck have made a breakthrough in cancer treatment with their personalized mRNA vaccine. According to Reuters, this vaccine significantly reduced the risk of melanoma returning or spreading.

The success of this vaccine opens up new avenues for cancer treatment, as doctors hope it will work against many types of tumors.

Moderna and Merck's achievement could usher in a new era of personalized cancer vaccines, providing patients with more targeted and effective treatments.